From: Relative resistance of HIV-1 founder viruses to control by interferon-alpha
Patient ID | Transmission risk group1 | Clade2 | Setpoint VL (copies/ml)3 | Virus isolation time-points (DFOSx)4 | IMCs generated6 |
---|---|---|---|---|---|
CH040 | MSM | B | 13,224 | None | Founder7 |
CH058 | MSM | B | 260 | 285 | Founder, 6-month7 |
CH077 | MSM | B | 3,631 | 215, 5925 | Founder, 6-month7 |
CH162 | HSX | C | 114,815 | None | Founder8 |
CH164 | HSX | C | 575,440 | None | Founder8 |
CH185 | HSX | C | 40,738 | None | Founder8 |
CH236 | HSX | C | 134,896 | None | Founder, 6-month9 |
CH264 | HSX | C | 74,131 | None | Founder9 |
CH470 | MSM | B | 23,442 | 335 | Founder, 6-month10 |
CH850 | HSX | C | 15,488 | None | Founder, 6-month9 |
MM23 | MSM | B | 82,958 | 14, 204, 631, 1535 | None |
MM24 | MSM | B | 128,021 | 16, 1322 | None |
MM25 | MSM | B | 72,600 | 10 | None |
MM26 | MSM | B | 34,493 | 69 | None |
MM27 | MSM | B | 48,360 | 28, 1516 | None |
MM28 | MSM | B | 12,322 | 6, 1995 | None |
MM33 | MSM | B | 73,958 | 12, 1912 | None |
MM34 | MSM | B | 8,522 | 25, 2227 | None |
MM38 | MSM | B | ND | 29 | None |
MM39 | MSM | B | 8,546 | 11, 1206 | None |
SUMA | MSM | B | 17,245 | None | Founder7 |